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Abstract
Duodenal cytochrome b (Dcytb or Cybrd1) is an iron-regulated protein, highly expressed in the duodenal brush border membrane. It has ferric
reductase activity and is believed to play a physiological role in dietary iron absorption. Its sequence identifies it as a member of the cytochrome b561
family. AHis-tagged construct of humanDcytb was expressed in insect Sf9 cells and purified. Yields of protein were increased by supplementation of
the cells with 5-aminolevulinic acid to stimulate heme biosynthesis. Quantitative analysis of the recombinant Dcytb indicated two heme groups per
monomer. Site-directed mutagenesis of any of the four conserved histidine residues (His 50, 86, 120 and 159) to alanine resulted in much diminished
levels of heme in the purified Dcytb, while mutation of the non-conserved histidine 33 had no effect on the heme content. This indicates that those
conserved histidines are heme ligands, and that the protein cannot stably bind heme if any of them is absent. Recombinant Dcytb was reduced by
ascorbate under anaerobic conditions, the extent of reduction being 67% of that produced by dithionite. It was readily reoxidized by ferricyanide.
EPR spectroscopy showed signals from low-spin ferriheme, consistent with bis-histidine coordination. These comprised a signal at gmax=3.7
corresponding to a highly anisotropic species, and another at gmax=3.18; these species are similar to those observed in other cytochromes of the b561
family, and were reducible by ascorbate. In addition another signal was observed in some preparations at gmax=2.95, but this was unreactive with
ascorbate. Redox titrations indicated an average midpoint potential for the hemes in Dcytb of +80 mV±30 mV; the data are consistent with either
two hemes at the same potential, or differing in potential by up to 60 mV. These results indicate that Dcytb is similar to the ascorbate-reducible
cytochrome b561 of the adrenal chromaffin granule, though with some differences in midpoint potentials of the hemes.
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Uptake of dietary non-heme iron through the duodenal brush
border membrane is one of the principal routes for assimilation of
this essential element. At least 4 proteins, DMT1, Dcytb,
ferroportin and hephaestin, have been implicated in the process
(for a review read Anderson and Frazer [1]). The divalent cation
transporter, DMT1 (also known as Nramp2, gene name Slc11a2),
is believed to be responsible for initial uptake of iron from the
duodenal lumen into the cells of the apical brush bordermembrane.
DMT1 is specific for iron in its ferrous (Fe2+) form, and since iron
exists predominantly in its oxidized ferric (Fe3+) form under the
physiological conditions of the lumen [2], it should be reduced
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fulfills many of the functional, positional and regulatory require-
ments for the ferric reductase. It is located in the brush border
membrane, and there is evidence that it can function in reduction of
ferric iron. In mice, Dcytb mRNA was shown to be strongly
induced by iron deficiency, hypoxia and chronic and hemolytic
anemias, all conditions in which iron absorption is increased [3]. In
the duodenal wall, the site of highest iron-transporting activity is
below the villus tip [4], and in situ hybridization showed Dcytb
mRNA to be present almost exclusively in mature enterocytes at
the villus tip, nearest to the intestinal lumen. Immunocytochemistry
showed that the protein was located maximally in the apical
membrane. The ability of Dcytb to catalyse the reduction of ferric
to ferrous iron complexes at the cell surface was demonstrated by
over-expression of the protein in cultured cell lines derived from
intestinal cells and also in Xenopus oocytes [5]. Dcytb may have a
broader role in cellular redox mechanisms; it is expressed in many
tissues. In humans it is expressed in erythrocytemembranes, where
it may contribute to reduction of extracellular dehydroascorbate. In
mice, by contrast, the protein is only expressed in erythroblasts and
is absent from mature erythrocytes [6].
The primary structure of Dcytb indicates that it is distinct
from ferric reductases previously characterized in yeast [7,6],
plants [8,9] and bacteria [10,11] and from STEAP3 of
hematopoietic tissues [12]. Instead, Dcytb shares extensive
structural homology (over 40% identity over the whole length)
with cytochromes b561, a class of proteins that transfer electrons
from ascorbate across membranes, such as that of the adrenal
chromaffin granule [13]. A topology model for cytochrome b561
[14,15,16] predicts an alpha-helical bundle with six putative
transmembrane domains, four of which (II, III, IV and V) con-
tain a single histidine heme-ligating residue. These residues
are appropriately located to form two heme iron coordination
complexes, located near the two surfaces of the membrane.
Biochemical evidence implicating two of these residues, His86
and His159, as heme iron coordinating ligands has come from
their individual site-directed mutation in recombinant cyto-
chrome b561 expressed using a yeast system; each mutation
resulted in the near elimination of a detectable difference heme
spectrum despite protein expression levels comparable to that of
wild-type [17]. The model was developed further by Okuyama
et al. [18] following the recognition of two fully conserved
sequences as potential substrate-binding domains. The first
(68ALLVYRV74) is located at the extra-vesicular end of alpha-
helix II, and in conjunction with Lys83 forms an ascorbate
recognition/binding site [17], while the second (119SLHSW123)
is thought to adopt an intra-vesicular location between helices II
and III, forming another ascorbate or dehydroascorbate-binding
site. This has led to a current mechanistic theory whereby the
two heme iron centres undergo redox cycling to provide a
conduit for electrons passing across the vesicle membrane, from
an ascorbate donor to the ascorbyl radical acceptor.
It is likely that many inferences relating to cytochrome b561
are also applicable to Dcytb. The hydropathy profile of Dcytb
indicates that it too forms six alpha-helical transmembrane
domains, while sequence alignments indicate that the putative
substrate-binding sites in cytochrome b561 are at least partiallyconserved [5]. The proposal that ascorbate acts as the
intracellular electron donor for Dcytb is supported by in vivo
measurements that showed an increase in duodenal ascorbate
levels in mice, induced to iron deficiency by feeding on an iron-
depleted diet, hypoxia or genetic hypotransferrinemia [19].
Elevated duodenal and plasma ascorbate levels have also been
associated with increased duodenal ferric reductase activity in
iron-deficient human subjects [20]. Moreover, Su and Asard [6]
have shown that in Δfre1Δfre2 mutant yeast cells, in which the
loss of endogenous ferric reductases can be complemented by
transformation with the Dcytb gene, the surface ferric reductase
activity is markedly increased when the transformed cells are
grown on media containing the ascorbate precursor L-galactono-
γ-lactone. A recent preliminary report on a canine kidney cell
line showed that Dcytb enhanced the reduction of both Fe3+ and
Cu2+ complexes in an ascorbate-dependent manner [21].
Apart from the inferences from sequences, information on
the physical properties of Dcytb is very limited. In this study our
aims were the determination of the presence and number of
hemes, the identification of residues that bind heme, and the
measurement of its oxidation-reduction properties. Preliminary
attempts to express the protein in sufficient quantities for pro-
tein characterization by using a yeast system were unsuccessful,
but finally sufficient quantities of the protein were obtained
using a baculovirus-mediated expression system.
2. Materials and methods
2.1. Materials
The baculovirus transfer plasmid pTriEx-1.1, BacVector-3000 triple cut
virus DNA, Sf9 insect cells, media and Bacplaque agarose were obtained from
Novagen. TOP10 One Shot Escherichia coli was from Invitrogen. QuikChange
site-directed mutagenesis kit was from Stratagene. Dodecyl-β-D-maltoside
(DDM) and Elugent were from Calbiochem. Immunopure Goat anti-rabbit IgG-
HRP conjugate and detergent compatible BCA assay kits, were obtained from
Pierce. Chromatographic columns and Western blotting materials were from
Amersham Biosciences. Centriprep and Centricon concentrators were from
Millipore. All other materials were obtained from Sigma or Merck.
2.2. Preparation of recombinant baculovirus and site-directed
mutagenesis
Human Dcytb cDNA was amplified by PCR techniques, introduced into
pTriEx-1.1 baculovirus transfer vector to enable addition of a C-terminal
histidine tag, and used to transform E. coli TOP10 cells. Plasmid DNA was
extracted from a single carbenicillin-resistant colony, screened by direct
sequencing and co-transfected into Sf9 cells with BacVector-3000 triple cut
virus DNA using the manufacturer's recommended protocols. Positive
recombinant baculovirus plaques were identified by Neutral Red staining,
followed by propagation and direct sequencing. Virus titres were calculated
using end point dilution assays, prior to expression studies.
Point mutations H33A, H50A, H86A, H120A and H159Awere incorporated
individually into the pTriEx-Dcytb transfer plasmid using the QuikChange kit,
with successful inclusion of each verified by direct sequencing. Baculovirus
stocks were generated as described above.
2.3. Insect cell cultures and Dcytb expression
Sf9 insect cells were grown in suspension cultures (28 °C, 150 rpm) for
baculovirus propagation or attached monolayers (28 °C) for transfection. Expres-
sionmediumwas supplemented with 61mg/l penicillin and 133mg/l streptomycin.
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at amultiplicity of infection (MOI) of 5–10 pfu/cell to 200ml suspension cultures of
Sf9 cells in logarithmic growth phase. Cells were incubated at 28 °C, 150 rpm and
harvested five days post-infection by centrifugation at 3000 ×g, 4 °C for 10 min.
The 5-aminolevulinic acid (ALA) supplementation study was carried out on
a 300 ml culture of Sf9 cells in logarithmic growth phase that was divided into
6×50 ml cultures. Five of these cultures were induced to express wild-type
Dcytb as described above, while the other was infected at identical MOI with a
baculovirus stock known to result in the expression of a non-heme, integral
membrane protein. Cultures containing Dcytb-expressing cells were supple-
mented 24 h post-infection with ALA to final concentrations from 0–1.0 mM,
while the non-hemoprotein expressing culture was supplemented 24 h post-
infection with ALA to a final concentration of 1.0 mM.
2.4. Preparation of insect cell microsomal membranes
Harvested cell pellets were subjected to repeated freeze–thaw cycles.
Subsequently, all membrane preparation steps were carried out at 4 °C, using
ice-cold buffers. Cells were resuspended in one-tenth of the culture volume
of 50 mM HEPES pH7.4, 250 mM NaCl, 30 mM imidazole (buffer A)
supplemented with protease inhibitors: 1 mM AEBSF, 1 μM bestatin, 1 μM
leupeptin, 1 μM pepstatin A, 100 μM E-64 and 2 μM phosphoramidon. Cells
were lysed by 3×10 s low-intensity sonication pulses in a sonicator bath and
heavy membrane fragments were pelleted by centrifugation at 2000 ×g for
10 min. The supernatant was removed and microsomal membranes were
recovered by centrifugation at 70,000 ×g for 1 h in a Beckman Ti45 rotor. Pellets
were washed with buffer A, prior to resuspension in one-tenth of the culture
volume of buffer A plus protease inhibitor cocktail. Elugent was added drop-
wise with stirring to a final concentration of 2% (v/v). Membrane proteins were
extracted using a magnetic stirrer at low revolutions for 1 h, and insolubilized
material was pelleted by centrifugation at 100,000 ×g for 1 h.
2.5. Immobilized metal affinity chromatography and sample preparation
All flow rates were maintained at 1 ml/min. Solubilized membrane proteins
were loaded onto a column containing Ni-nitrilotriacetate (NTA) agarose,
equilibrated with 10 column volumes of buffer A, 2% Elugent. The column was
washed with 15 column volumes of buffer A, 0.05% DDM to remove unbound
proteins, and to perform a detergent exchange. Bound proteins were then eluted
with 10 column volumes of buffer A, 0.05% DDM supplemented with elevated
imidazole concentrations, and collected in 1 ml fractions. Fractions containing
Dcytb were concentrated using Centricon or Centriprep YM-50 concentrators at
3000 ×g, 4 °C. Residual imidazole was removed by dialysis against three
changes of buffer A, 0.05% DDM at 4 °C, using a 10 kDa molecular weight cut-
off dialysis membrane. Dialysis buffer was adjusted to pH7.0 for potentiometric
titrations. Protein concentrations were determined using a detergent compatible
BCA assay kit with bovine serum albumin as a standard.
2.6. Protein analysis
Standard techniques were used for resolving fractions on 12% SDS-PAGE
gels [22]. 20 μl samples were diluted in an equal volume of Laemmli sample
buffer at room temperature prior to electrophoresis at a constant 120 V. For
Western blotting and N-terminal sequencing, fractions were then electroblotted
overnight onto nitrocellulose paper at a constant 15 V, 4 °C. Western blots were
developed using the ECL detection system, according to manufacturer's pro-
tocols. Briefly, active sites on the nitrocellulose paper were blocked for 1 h with
PBS+1% (w/v) powdered milk. Blots were then probed with rabbit anti-Dcytb
antibody (1:250 dilution in PBS) for 1 h, followed by 4×5 min washes with
PBS. Following incubation for 30 min with secondary antibody (goat anti-rabbit
IgG-HRP, 1:40,000 dilution in PBS) and 4×5 min washes, blots were soaked in
ECL developing solution for 5 min. Immunoreactive bands were visualized by
autoradiography on Fuji X-ray film. N-terminal sequencing was conducted on
an Applied Biosystems 473A protein sequencer.
To visualize hemoproteins following electrophoresis, fractions containing
Dcytb were resolved according to the protocol previously recommended [23],
using 0.1% lithium dodecyl sulfate (LDS) in the sample and running buffersinstead of SDS. Electrophoresis was conducted at a constant 90 V, 4 °C for 3 h.
Staining was performed as previously described [24], based on the heme-
associated, peroxidase-mediated formation of a blue precipitate from 3,3′-5,5′-
tetramethylbenzidine.
2.7. Heme content analysis
Heme content of Dcytb samples was analyzed using the pyridine hemo-
chromogen method as described previously [25]. The ferricyanide-oxidized
spectrum was subtracted from the dithionite-reduced spectrum and heme b
content was calculated using an extinction coefficient difference (556 nm–
540 nm) of 24 mM−1 cm−1.
2.8. Absorbance spectroscopy
200 μl samples were fully oxidized with addition of a small amount of
ferricyanide and subjected to UV–visible absorbance spectroscopy at room
temperature on a Synergy HTmulti-detection microplate reader (Bio-Tek), using
sample buffer as a blank. Samples were then fully reduced by the addition of
sodium dithionite, and the absorption was measured over the same wavelength
range. Difference spectra were obtained by subtracting the oxidized spectrum
from the dithionite-reduced spectrum. For ascorbate reduction, Dcytb samples
(0.1 mg/ml) were stirred under nitrogen for 1 h on ice. Measurements were
performed with constant stirring in a stoppered self-masking cell under nitrogen
flow. 50 μM ferricyanide was added until the sample was fully oxidized, as
determined by stabilization of the 414 nm peak. 10 μl aliquots of 100 mM
ascorbate in buffer A, pH7.5 were then added sequentially, with absorbance
between 380 and 600 nm recorded 2 min after each addition. Once the spectrum
had displayed maximal ascorbate reduction a few grains of sodium dithionite
were added to fully reduce the sample.
2.9. EPR spectroscopy
Recombinant Dcytb was extracted, purified and concentrated to 70 µM as
described above. Samples were frozen in liquid nitrogen prior to EPR analysis.
Spectra were recorded at X-band continuous-wave mode, on a Bruker Elexsys
E580 spectrometer or ESP300 spectrometer with an ER4122 Super-High-Q
Cavity and an Oxford Instruments ESR900 helium flow cryostat.
2.10. Potentiometric titrations
Optically monitored potentiometric titrations were carried out in a 1 mm
path-length quartz cuvette designed to perform magnetic circular dichroism with
in situ potentiometric control (MOTTLE cell) [26]. Briefly, the cuvette was
fitted with a gold mini-grid working electrode (60% optical transmission), and
coated with cystamine prior to use. A platinum wire formed the counter
electrode, and a silver chloride coated silver wire the reference electrode. Before
sealing the cuvette cell with a rubber gasket, the reference electrode was
calibrated by cyclic voltammetry of 100 μM potassium ferricyanide solution in
50 mM HEPES, 250 mM NaCl, pH7 buffer-electrolyte.
Dcytb samples were stirred under argon for 1 h on ice. A cocktail of mediators
was added to a final concentration of 40 μM for each mediator: tetramethyl-
phenylene diamine (240 mV vs. SHE), ruthenium hexamine chloride (201 mV),
trimethylhydroquinone (100 mV), 5-hydroxynaphthoquinone (45 mV), duroqui-
none (7 mV), menadione (−80 mV), anthraquinone-2,6-disulfonate (−185 mV),
anthraquinone-2-sulfonate (−225 mV), 5 μM benzyl viologen (−368 mV) and
sulfonyl viologen (−390 mV). For the potential window investigated here the
mediator cocktail showed negligible contribution to the electronic absorption
spectrum. The spectroelectrochemical cell, flushedwith argon gas, was loadedwith
100μl Dcytb (at a final concentration of 100 μM)-mediator solution and positioned
inside a JASCO V-550 UV–visible spectrophotometer. This was connected to an
Autolab PGSTAT 12 potentiostat controlled by GPES software.
A cyclic voltammogram was recorded to check the cell response and the
integrity of the electrode connections. The desired potential was then applied to
the sample and the approach to equilibrium monitored by the decrease in current
magnitude to a negligible value and stabilization of the electronic absorbance at
Fig. 2. UV–visible spectroscopy. (A) ALA supplementation of insect cell medium
significantly increased the proportion of holo-Dcytb recovered. Reduced-minus-
oxidized difference spectra were recorded from crude membrane fractions
prepared from Sf9 cells expressing Dcytb without ALA supplementation (broken
line), or with varying concentrations of ALA supplementation as noted. These are
compared to the difference spectrum of a crude membrane preparation from Sf9
cells expressing a non-heme, integral membrane protein in the presence of 1 mM
ALA (dotted line). All preparations were adjusted to 2 mg/ml total protein content
prior to analysis. (B) Absorbance spectra of purified Dcytb in the UV–visible
wavelength range following ferricyanide oxidation (broken line), dithionite
reduction (solid line) or 15 mM (final concentration) ascorbate partial reduction
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absorption spectrum of the sample was then recorded. The potentiostat was set
onto galvanostat mode to define the potential of the solution immediately after
each spectrum had been recorded. The set and read-back potentials were
typically within 30 mV of each other unless in a region of potential coinciding
with a gap in the mediator potential range.
3. Results
3.1. Baculovirus-mediated Dcytb expression
Dcytb protein was localised exclusively to the membrane
fraction, as indicated by a 30 kDa immunoreactive band in a
Western blot of crude membrane extracts. (Fig. 1B, lane 2).
Optimal yields of the cytochrome were obtained five days post-
infection using a MOI value of 5. From a selection of detergent
conditions tested, 2% Elugent provided the highest recovery
rate of Dcytb from membrane preparations (data not shown).
Dcytb could be isolated from microsomal membranes to
approximately 90% purity using Ni2+-NTA chromatography,
as assessed by densitometric analysis of the Coomassie stained
gels. We found that by employing a stringent primary elution of
150 mM imidazole we were able to remove the majority of
contaminating proteins with only minor losses of recombinant
protein (Fig. 1A and B, lanes 4 and 5).
Although N-terminal sequencing verified that the protein
forming the major band at 30 kDa was Dcytb, two accompany-
ing bands were also evident in 500 mM imidazole elution
fractions, and both were immunoreactive to anti-Dcytb antibody
(Fig. 1B, lane 5), suggesting the formation of Dcytb homo-
dimers and -trimers. These complexes could be disrupted
completely by heating samples at 100 °C for 5 min prior to
electrophoresis, after which a single band slightly below 30 kDa
was visualized (Fig. 1B, lane 6). The slightly higher electro-
phoretic mobility of the heated sample may represent mono-
meric Dcytb in a fully denatured form, or Dcytb lacking heme
cofactors. All three immunoreactive bands could be eliminatedFig. 1. Dcytb content of fractions collected during expression, extraction and
purification protocols. Fractions were resolved by 12% SDS-PAGE, followed by
either Coomassie staining (A), or transfer to nitrocellulose membrane and
Western blotting with anti-Dcytb antibody (B). In both panels, lanes 1 and 2
respectively: Sf9 cell soluble and total membrane fractions; lane 3: Ni2+-NTA
column flow-through; lane 4: 150 mM imidazole elution; lane 5: 500 mM
imidazole elution. (B) Lane 6: 500 mM imidazole elution fraction boiled for
5 min. Broad range molecular weight markers are shown on the left-hand side.
(C) In-gel heme stain of 500 mM imidazole elution fraction containing holo-
Dcytb. The membrane preparation used was collected from Dcytb-expressing
insect cells, grown in medium which was supplemented with 1 mM ALA 24 h
after baculovirus infection.
(dotted line). Each spectrumwas recorded under anaerobic conditions as described
in Materials and methods.by pre-incubation of the anti-Dcytb antibody with the peptide
used to raise the antibody (not shown). Dcytb was consistently
recovered in purified preparations at yields of 3–4 mg/l cell
culture; the inclusion of 0.05% DDM enabled us to concentrate
preparations to 6 mg/ml on 30 kDa molecular weight cut-off
membranes without significant accumulation of surfactant.
3.2. ALA supplementation increases heme incorporation into
Dcytb
Despite the high Dcytb concentrations achieved, initially it
was clear from the absence of a distinct heme spectrum that the
majority of the protein was present in the apo-form. As was
shown in a previous study on recombinant adrenal cytochrome
b561 [27], supplementation of the medium with ALA (a pre-
cursor in the heme biosynthetic pathway), added 24 h post-
infection, greatly enhanced the heme content of Dcytb in insect
cells. This was observed as it increased the peak amplitudes in
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(Fig. 2A). Comparisons with similar preparations from Sf9 cells
induced to express a non-heme, integral membrane protein in
ALA supplemented media indicated that the spectra obtained
were direct measurements of Dcytb and not an endogenous
hemoprotein. Heme loading increased with ALA supplementa-
tion up to 1 mM, above which a significant reduction in Dcytb
expression was observed. At this level of ALA supplementation
heme content analysis, coupled to a detergent compatible BCA
assay to estimate protein concentration, indicated that an aver-
age of 1.67 heme b was present per Dcytb monomer. In-gel
heme staining of heme-loaded Dcytb fractions resolved by
LDS-PAGE produced a similar band profile to that obtained by
Western blotting (Fig. 1C), with a major band at 30 kDa and two
other bands at approximately 60 kDa and 90 kDa.
UV–visible absorption spectroscopy of oxidized Dcytb
indicated the presence of a characteristic Soret band at
413 nm. This shifted to 424 nm after full reduction by dithionite,
and was accompanied by the detection of a single α band at
560 nm, and a smaller β band at 529 nm. There is a slight
asymmetry in the lower-wavelength side of the α band of the
partially-reduced cytochrome, as observed in the spectrum of
cytochrome b561 by Kamensky et al. [28] (see Fig. 5A); this may
reflect the presence of two hemes with somewhat different
absorption spectra. The difference spectra for Dcytb displayed in
Fig. 2A are characteristic of a b-type cytochrome, as expected.Fig. 3. (A) EPR spectra of purified recombinant Dcytb after metal affinity chromatogr
for 2 min, recorded at 9.5 K. Conditions of measurement were: microwave power 2
recombinant Dcytb, prepared by detergent extraction without sonication d) recorded
ascorbate-reduced. Conditions as for (A), except microwave frequency 9.38 GHz.Dcytb was reducible by ascorbate under anaerobic conditions
(Fig. 2B), with the proportion of reduced cytochrome increasing
in a concentration dependent manner up to 15 mM ascorbate,
above which no further reduction was observed. The relative
absorbance of the difference spectrum at 560 nm (α band)
indicated that Dcytb was 67% reducible by ascorbate in
comparison to dithionite reduction.
3.3. EPR spectroscopic measurements
Recombinant Dcytb in the oxidized state showed an EPR
spectrum at temperatures around 12K, typical of low-spin ferric
heme. Fig. 3A shows a sample from the same batch as that used
for redox titrations. The gz=3.7, 3.18 components are similar to
those observed in CG cytochrome b562 from adrenal chromaffin
granules [29,28]. This spectrum is consistent with the presence
of two hemes in the cytochrome. The highly anisotropic gmax=
3.7 feature is from a more rapidly-relaxing species that was not
perceptible at temperatures above 12 K (Fig. 3Aa and b). Signals
at gN3.3 are characteristic of the highly anisotropic low-spin
form seen in some other bis-histidine heme compounds and
proteins [30].
Preparations of Dcytb often also displayed a signal at g1=
2.95, g2=2.25 in addition to the signal at gmax=3.18. In ex-
treme cases the gmax=2.95 feature was very prominent, and the
signal at gmax=3.7 was undetectable (Fig. 3Bd). The gmax=3.7,aphy, a) recorded at 17 K; b) recorded at 9.5 K; c) reduced with 10 mM ascorbate
0 mW, frequency 9.40 GHz, modulation amplitude 1 mT. (B) EPR spectrum of
at 12 K; e) reduced with 5 mM ascorbate, 12 K; f) difference, oxidized minus
Fig. 4. Expression and difference spectra of Dcytb mutants. Mutated Dcytb was prepared as described for wild-type in Materials and methods and resolved by 12%
SDS-PAGE, followed by (A) Coomassie staining, or (B) transfer to nitrocellulose membrane and Western blotting with anti-Dcytb antibody. (C) Reduced-minus-
oxidized difference spectra of mutated vs. wild-type Dcytb preparations. Samples were adjusted to 0.5 mg/ml with 50 mMHEPES pH7.4, 250 mMNaCl, 0.05% DDM
prior to spectroscopic analysis of 200 μl in a 96 well plate reader. Results shown are representative of three individual preparations of each mutant.
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ibility by ascorbate. In the sample shown in Fig. 3A, the EPR
signal at gmax=3.18 disappeared, while the signal at gmax=3.7
was substantially decreased (Fig. 3Ac). Fig. 3B shows spectra
of another sample, prepared by a method that involved detergent
extraction without sonication. The gmax=3.7 signal in this prep-
aration was relatively low. On reduction by ascorbate (Fig. 3Be),
the gmax=3.18 signal was reduced, as seen in the difference
spectrum (Fig. 3Bf) but the gmax=2.95 signal was apparently
unchanged. This indicates that the gmax=2.95 species either hasFig. 5. Dcytb potentiometric titration. A 100 μM purified Dcytb sample was mixed w
status was monitored in a MOTTLE cell at pH7.0 under anaerobic conditions. (A) Dif
the reductive titration, showing a normal reduction profile. Inset is a magnified view
measured by absorbance at 560 nm–572 nm, against potential vs. SHE (standard hyd
Em=58 mV and 108 mV (coefficient of determination r
2=0.9965), and (┈) for onea lower redox potential than the other hemes, or is unreactive
with ascorbate.
3.4. Sequence-directed mutagenesis
To investigate the identity of the heme-ligating His residues
indicated by EPR analysis, we generated site-directed mutants
of candidates from a sequence alignment with cytochromes b561
[5]. Expression levels of mutants H33A, H50A, H86A, H120A
and H159A by Sf9 cells in 1.0 mM ALA supplemented mediaith various potential mediators as described in Materials and methods and redox
ference spectra at equilibrated potentials between −197 mVand +241 mV during
of the apha- and beta-bands. (B) Redox titration profile plotting % reduction, as
rogen electrode). Fits to the Nernst equation; (─) for two reduction potentials of
reduction potential of Em=83 mV (r
2=0.9944).
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B). In each case the mutated protein was located exclusively to
the membrane fraction and could be extracted in similar yields
to the wild-type protein. The H50A and H120A mutants ap-
peared to be properly processed and targeted in Sf9 cells, in
contrast to the corresponding mutants of cytochrome b561 when
expressed in yeast [17]. The effect on heme binding conferred
by each mutation was assessed by comparing the difference
spectra of 0.5 mg/ml samples of the Dcytb mutants to the wild-
type protein. His33 was mutated as a control; it is not conserved
between Dcytb and cytochrome b561 but is proposed to be
positioned within transmembrane alpha-helix I. The difference
spectrum for the mutant in the non-conserved His33 was similar
to the wild-type in terms of band position and amplitude, sug-
gesting that the mutation did not significantly affect the overall
processing and folding of Dcytb. However each of the muta-
tions of the other histidine residues resulted in a substantial,
though not complete, loss of the heme spectrum.
3.5. Dcytb potentiometry
As the Dcytb sample was found to be slightly reduced prior to
amperometry an initial oxidative poising was performed to
record a fully oxidized UV–visible spectrum. A full reductive
titration from +241 mV to −180 mV was performed at ambient
temperature, followed by a partial re-oxidation. Fig. 5A shows
the difference spectra (reduced minus oxidized) for the b hemes
in Dcytb, equilibrated at various potentials during the reductive
titration. Fig. 5B shows the titration profile for Dcytb, plotting%
reduction as monitored by the increase in intensity of the α band
at 560 nm. The absorbance difference 560 nmminus the 572 nm
isosbestic point is plotted to correct for any baseline shifts and
mediator contribution in this region of the spectra. The reduction
profile shows a continuous sigmoid curve with no inflexion. It
was possible to obtain a reasonable fit to the data with a single
reversible one-electron Nernstian process with a reduction
potential of +86 mV (solid line). A somewhat better fit could be
obtained with two components, each at 50% intensity, with
reduction potentials of +110 mV and +60 mV (dotted line).
Resolution of the Nernst curves of two components is difficult if
the difference in potential is less than 40 mV [31]. Similar cases
of heme proteins with overlapping redox potentials have been
described, such as chloroplast cytochrome b6 [32].
By comparison, the potentials of the two hemes in CG
cytb561 are somewhat more positive than those of Dcytb, and
sufficiently separated to be fitted to two components. Apps et al.
[33] fitted their redox data to potentials of 170 and 70 mV for
the soluble protein, and 135 and 55 mV for the membrane-
bound form.
4. Discussion
The duodenal enterocyte represents the major regulatory site
controlling iron homeostasis in mammals. Dcytb has been
shown to be a transmembrane protein, with ferric reductase
activity, and to be expressed in the intestine. Both mRNA and
protein are high regulated by iron status of the body, and theenzyme is thought to play an important role in absorption of
dietary iron, at least in humans. However there are probably
multiple pathways of iron reduction. Gunshin et al. [34] reported
that Dcytb knockout mice, when grown either under normal or
iron-limited conditions, did not become anemic and showed
only amodest decrease in liver iron content. They concluded that
Dcytb is not essential for intestinal iron uptake under the growth
conditions used. This does not rule out a role of Dcytb in iron
reduction however [35]. Mice of the strain used (129S6SvEx-
Tac) have unusually high liver iron levels and do not become
anemic when fed an iron-deficient diet, whereas other mouse
strains and humans might be expected to do so [34,36]. On a
normal diet there may be a significant non-enzymic reduction of
iron by reducing compounds in the intestine. Moreover mice,
unlike humans, are able to synthesize ascorbate and might
secrete ascorbate into the gastrointestinal tract, so there would be
no absolute requirement for a surface ferric reductase. Further
work is needed on compensatory mechanisms of duodenal iron
reduction and absorption.
The development of an expression system to address these
questions is therefore timely. It complements those described for
recombinant cytochrome b561, expressed in Sf9 cells, P. pastoris
[27] and S. cerevisiae [17].
4.1. The number of hemes per molecule
Heme content analyses of Dcytb derived from Sf9 cells
growing in medium supplemented with ALA indicate that our
preparations contained an average of ≈1.7 heme b per Dcytb
monomer indicating that Dcytb is a di-heme protein. The EPR
spectra are also consistent with the presence of two different
hemes in equal concentrations. This is similar to data on CG
cytochrome b561 which indicated a heme b: protein monomer
ratio of 2:1 [27,29]. In addition, the Dcytb EPR spectrum at 12 K
has similar features to those of cytochrome b561 recorded at 15 K
[27–29]. The presence of two hemes with bis-histidine co-
ordination is supported by the site-directed mutagenesis studies,
in which the substitution of any of the identified four Dcytb
histidine residues led to a loss of most, but not all, of the heme
spectrum. The equivalent histidine residues are conserved in the
cytochrome b561 sequence, and have been shown to be required
for Fe3+ reductase activity [17], or following point mutation of
lysosomal cytochrome b561 expressed in Δfre1Δfre2 mutant
yeast cells [6]. Substitution of the non-conserved His33 had
negligible effect on heme binding, as was observed for mutation
of the equivalent histidine in cytochrome b561. Protein
expression levels were unchanged in each case. Similar results
were reported for CG cytochrome b561 [17,28]. These results
indicate a cooperative binding of hemes, such that binding of
heme to either site facilitates the insertion of heme into the other,
or stabilizes it once inserted. Studies of synthetic four-helix
protein maquettes containing pairs of hemes with bis-histidyl
coordination have shown that, in some cases, loss of one
histidine destabilizes the structure of the whole [37]. The calcu-
lated Dcytb extinction coefficients in our preparations were
approximately 228 mM− 1 cm− 1 (428 nm–411 nm) and
29 mM−1 cm−1 (560 nm–575 nm), although these are minimal
267J.S. Oakhill et al. / Biochimica et Biophysica Acta 1777 (2008) 260–268estimates due to partial heme loading. The values are slightly
lower than representative values for cytochrome b561 from
bovine adrenal glands [29].
The samples prepared during this study had a tendency to
form homo-dimeric and homo-trimeric Dcytb complexes, in-
dicating some heterogeneity in the preparations (Figs. 1 and 4).
Mammalian cytochrome b561 [38] and a plant homologue
isolated from etiolated bean hypocotyls [39] were also reported
to form aggregates in detergent solubilized extracts. It is un-
likely that this oligomerization of recombinant Dcytb is due to
non-specific interactions between histidine affinity tags since
we and others have observed the effect in membrane extracts of
mammalian cultured cells expressing Dcytb without an affinity
tag (data not shown) and in murine duodenal lysates [34]. The
physiological relevance of cytochrome b aggregation is unclear
at the present time.
The EPR spectra of the recombinant Dcytb comprised dif-
fering amounts of three heme species, depending on the prepa-
ration, with gmax=3.7, 3.18 and 2.95. The gmax=3.18 species
was always present, but the gmax=3.7 and 2.95 signals appeared
to represent alternative species. The most recent preparations,
obtained by ultrasonic treatment and purified on the Ni-NTA
column, showed a more prominent gmax=3.7 signal (Fig. 3A),
similar to those seen in other cytochromes of the b561 family
[28]. In the classification of Walker [30, 40] this highly aniso-
tropic signal represents a Type I heme, in which the imidazole
planes of the coordinating histidines are orthogonal. Other prep-
arations, such as the sample prepared by detergent extraction
without sonication in Fig. 3B, showed a more prominent
gmax=2.95 signal which was associated with a second g-factor
of 2.25. This represents a Type II heme, in which the imidazole
rings are closer to parallel [30]. These data can be interpreted in
terms of a structural modification of the protein, in which the
gmax=3.7 heme is converted from Type I to Type II. The reason
for the change in coordination in Dcytb remains to be
established. Such changes in conformation have been observed
in CG cytochrome b561, where the heme with gmax=3.1 could be
modified by treatment with ferricyanide at alkaline pH, giving a
species with gmax=2.84 [29]. Takeuchi et al. [16] also described
a form of CG cytochrome b561, obtained by treatment with a
cysteine-modifying agent, in which the gmax=3.1 species was
converted to a form with gmax=2.94. Interestingly, this form
was not reducible by ascorbate.
4.2. On the function of Dcytb
The present study indicates that recombinant Dcytb contains
two hemes that are at least partially ascorbate-reducible. In a
static reduction experiment, 67% of the heme was reduced by
ascorbate. The measured midpoint potentials of the hemes
indicate that the ascorbyl radical/ascorbate couple at +320 mV
[41,42] would not be sufficient to carry out the reduction. More
likely it is the reducing couple which is dehydroascorbate/
ascorbate, which has a potential of +58 mV. Dehydroascorbate
is unstable, being converted to 2,3-dioxogulonate, on a time-
scale of several minutes [43] which would drive the reduction
further. In vivo, dehydroascorbate would be kept at very lowlevels by being rapidly re-reduced to ascorbate, for example by
reaction with glutathione. The binding site for ascorbate in
cytb561 is conserved in the sequence of Dcytb [5]. The hemes
have the necessary reduction potential to transfer electrons to
Fe3+, and the protein is oxidized by ferricyanide. Nevertheless
it is difficult to establish unequivocally from studies of the
recombinant protein, that the sole physiological role of Dcytb is
as a specific ascorbate-dependent Fe3+ reductase. Firstly, Dcytb
has the capacity to reduce other electron acceptors such as
tetrazolium [5]. Secondly, ascorbate and Fe3+ complexes will
rapidly react with each other in free solution. Some support for
ascorbate as the electron donor to Dcytb is the conservation of
residues Arg70, Lys83, His86 and His159 which in b561 have
been implicated in ascorbate-binding using diethyl pyrocarbo-
nate modification studies [44] and site-directed mutagenesis
[17]. In addition, the measured midpoint potential of +80 mV
for purified Dcytb correlates well with that of the lower redox
potential heme species of cytochrome b561 (+70 mV, [33]),
which is proposed to act as the electron acceptor from cyto-
plasmic ascorbate [29]. The best functional evidence at present
comes from the studies already mentioned, [6,19,20] which
showed that expression of Dcytb in cell membranes enhanced
the reduction of Fe3+ in an ascorbate-dependent manner.
In summary, this is the first report of the isolation of Dcytb,
the protein which is most highly induced in the enterocyte
during iron deprivation [3]. The data provide direct evidence
that the cytochrome contains two heme groups per molecule and
identify four critical histidine residues predicted to be involved
in heme binding. In these respects, and in spectroscopic
properties, Dcytb is similar to other cytochromes of the b561
family. We have measured the midpoint reduction potentials of
the hemes, and shown that they are reducible by ascorbate
indicating this as a likely intracellular electron donor.
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